PRKD1 and neoplasm: To gain a systems level understanding of PKD contribution to TNBC secretion, we assessed the effect of PKD inhibition on the previously validated invasion mediators in an expanded panel of TNBC cell lines consisting of 6 cell lines originally established from the primary tumor and 4 metastatic cell lines from pleural effusions67,68,69,70,71 (Table S5).